Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers

Por Pooja Srivastava, Tiannan Wang, Beth Z. Clark, Jing Yu, Jeffrey L. Fine, Tatiana M. Villatoro, Gloria J. Carter, Adam M. Brufsky, Vikram C. Gorantla, Shannon L. Huggins-Puhalla, Leisha A. Emens, Thais Basili, Edaise M. da Silva, Jorge S. Reis-Filho, Rohit Bhargava
Publicado em 2022-04-01